Hemiballismus

Current Treatment Options in Neurology

Volumn 7, Issue 3, 2005, Pages 203-210

  Shannon, Kathleen M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CARBAMAZEPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUPHENAZINE; GABAPENTIN; HALOPERIDOL; IBUPROFEN; LEVODOPA; LITHIUM; NEUROLEPTIC AGENT; ORAL CONTRACEPTIVE AGENT; PERPHENAZINE; PIMOZIDE; PROGABIDE; RESERPINE; RISPERIDONE; SERTRALINE; TETRABENAZINE; VALPROIC ACID;

AGING; AGRANULOCYTOSIS; AKATHISIA; ANTICHOLINERGIC EFFECT; ARTICLE; BODY WEIGHT DISORDER; BONE MARROW SUPPRESSION; BRAIN DISEASE; BRAIN INFECTION; BRAIN METABOLISM; BRAIN NUCLEUS; BRAIN REGION; BREAST ENGORGEMENT; CARDIOMYOPATHY; CEREBROVASCULAR DISEASE; CHOREA; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISEASE COURSE; DIZZINESS; DROWSINESS; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG POTENTIATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHORIA; ENCEPHALITIS; EOSINOPHILIA; EXHAUSTION; EXTRAPYRAMIDAL SYMPTOM; GYNECOMASTIA; HEART ARREST; HEART ARRHYTHMIA; HEMIBALLISM; HEPATITIS; HUMAN; HYPERGLYCEMIA; HYPOTENSION; INJURY; LACTATION; LONG TERM CARE; LOW DRUG DOSE; LUNG EMBOLISM; METABOLIC DISORDER; MOTOR DYSFUNCTION; MYOCARDITIS; NEUROLEPTIC MALIGNANT SYNDROME; NEUTROPENIA; NONHUMAN; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PATIENT SELECTION; PROGNOSIS; QT PROLONGATION; RESPIRATORY FAILURE; RISK REDUCTION; SALIVATION DISORDER; SEDATION; SEIZURE; SOMNOLENCE; STEREOTAXIC SURGERY; SUBTHALAMIC NUCLEUS; SURVIVAL RATE; TACHYCARDIA; TARDIVE DYSKINESIA; TORSADE DES POINTES; TREATMENT INDICATION; WEIGHT GAIN;

EID: 21244448837     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-005-0013-3     Document Type: Article

References (36)

1. Dewey Jr RB, Jankovic J: Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients. Arch Neurol 1989, 46:862-867.
2. Pekmezovic T, Svetel M, Ristic A, et al.: Incidence of vascular hemiballism in the population of Belgrade. Mov Disord 2004, 19:1469-1472.
3. Postuma RB, Lang AE: Hemiballism: revisiting a classic disorder. Lancet Neurol 2003, 2:661-668.
4. Lee BC, Hwang SH, Chang GY: Hemiballismus-hemichorea in older diabetic women: a clinical syndrome with MRI correlation. Neurology 1999, 52:646-648.
5. Kostic V, Djuricic B, Paschen W: Hemiballismus: changes in cerebrospinal fluid. Acta Neurol Scand 1988, 78:115-17.
6. Crossman AR, Sambrook MA, Jackson A: Experimental hemichorea/hemiballismus in the monkey. Studies on the intracerebral site of action in a drug-induced dyskinesia. Brain 1984, 107:579-596.
7. Ristic A, Marinkovic J, Dragasevic N, et al.: Long-term prognosis of vascular hemiballismus. Stroke 2002, 33:2109-2111.
8. Ghika-Schmid F, Ghika J, Regli F, Bogousslavsky J: Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry. J Neurol Sci 1997, 146:109-116.
9. Klawans HL, Moses H, Nausieda PA, et al.: Treatment and prognosis of hemiballismus. N Engl J Med 1976, 295:1348-1350.
10. Johnson WG, Fahn S: Treatment of vascular hemichorea and hemiballismus with perphenazine. Trans Am Neurol Assoc 1974, 99:222-224.
11. Evidente VG, Gwinn-Hardy K, Caviness JN, Adler CH: Risperidone is effective in severe hemichorea/hemiballismus. Mov Disord 1999, 14:377-379.
12. Stojanovic M, Sternic N, Kostic VS: Clozapine in hemiballismus: report of two cases. Clin Neuropharmacol 1997, 20:171-174.
13. Pearce J: Reversal of hemiballismus by tetrabenazine. JAMA 1972, 219:1345.
14. Obeso JA, Marti-Masso JF, Astudillo W, et al.: Treatment with hemiballism with reserpine. Ann Neurol 1978, 4:581.
15. Kothare SV, Pollack P, Kulberg AG, Ravin PD: Gabapentin treatment in a child with delayed-onset hemichorea/hemiballismus. Pediatr Neurol 2000, 22:68-71.
16. Gonce M, Schoenen J, Charlier M, Delwaide PJ: Successful treatment of hemiballismus with progabide, a new GABA-mimetic agent. J Neurol 1983, 229:121-124.
17. Hordnes J, Moen G, Tysnes OB: [Hemiballismus in cerebral infarction]. Tidsskr Nor Laegeforen 2001, 121(22):2593-2595.
18. Dressler D, Wittstock M, Benecke R: Treatment of persistent hemiballism with botulinum toxin type A. Mov Disord 2000, 15:1281-1282.
19. Levesque MF, Markham C, Nakasato N: MR-guided ventral intermediate thalamotomy for posttraumatic hemiballismus. Stereotact Funct Neurosurg 1992, 58:88.
20. Jallo GI, Dogali M: Ventral intermediate thalamotomy for hemiballismus. Stereotact Funct Neurosury 1995, 65:23-25.
21. Tsubokawa T, Katayama Y, Yamamoto T: Control of persistent hemiballismus by chronic thalamic stimulation. Report of two cases. J Neurosurg 1995, 82:501-505.
22. Slavin KV, Baumann TK, Burchiel KJ: Treatment of hemiballismus with stereotactic pallidotomy. Case report and review of the literature. Neurosurg Focus 2004, 17:E7.
23. Kurita H, Kawamoto S, Sasaki T, et al.: Relief of hemiballism from a basal ganglia arteriovenous malformation after radiosurgery. Neurology 1999, 52:188-190.
24. Johnson WG, Fahn S: Treatment of vascular hemiballism and hemichorea. Neurology 1977, 27:634-636.
25. Emre M, Landis T: Haloperidol in hemichorea-hemiballismus. J Neurol 1984, 231:280.
26. Gilbert GJ: Response of hemiballismus to haloperidol. JAMA 1975, 233:535-536.
27. Carella A: [A case of hemiballismus cured with chlorpromazine and butyrophenone]. Acta Neurol (Napoli) 1966, 21:46-54.
28. Friedman JH: Atypical antipsychotics in the EPS-vulnerable patient. Psychoneuroendocrinology 2003, 28(Suppl 1):39-51.
29. Chandra V, Wharton S, Spunt AL: Amelioration of hemiballismus with sodium valproate. Ann Neurol 1982, 12:407.
30. Okun MS, Riestra AR, Nadeau SE: Treatment of ballism and pseudobulbar affect with sertraline. Arch Neurol 2001, 58:1682-1684.
31. Krauss JK, Mundinger F: Functional stereotactic surgery for hemiballism. J Neurosurg 1996, 85:278-286.
32. Vitek JL, Chockkan V, Zhang JY, Kaneoke Y, et al.: Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. Ann Neurol 1999, 46:22-35.
33. Carod-Artal FJ, Vargas AP, Marinho PB, et al.: [Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome)]. Rev Neurol 2004, 38:327-331.
34. Bujanover S, Levy Y, Katz M, et al.: Lack of association between anti-phospholipid antibodies (APLA) and Attention Deficit/Hyperactivity Disorder (ADHD) in children. Clin Dev Immunol 2003, 10:105-109.
35. Burstein L, Breningstall GN: Movement disorders in bacterial meningitis. J Pediatr 1986, 109:260-264.
36. Im SH, Oh CW, Kwon OK, et al.: Involuntary movement induced by cerebral ischemia: pathogenesis and surgical outcome. J Neurosurg 2004, 100:877-882.